1. Home
  2. GALT vs DSAC Comparison

GALT vs DSAC Comparison

Compare GALT & DSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

N/A

Current Price

$2.90

Market Cap

397.3M

Sector

Health Care

ML Signal

N/A

Logo Daedalus Special Acquisition Corp. Class A Ordinary Shares

DSAC

Daedalus Special Acquisition Corp. Class A Ordinary Shares

SELL

Current Price

$10.07

Market Cap

343.9M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
GALT
DSAC
Founded
2000
2025
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
397.3M
343.9M
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
GALT
DSAC
Price
$2.90
$10.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
185.4K
★ 188.4K
Earning Date
11-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 36.84
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$9.90
52 Week High
$7.13
$10.47

Technical Indicators

Market Signals
Indicator
GALT
DSAC
Relative Strength Index (RSI) 35.26 36.15
Support Level $2.78 $9.90
Resistance Level $3.30 $10.18
Average True Range (ATR) 0.30 0.01
MACD -0.03 -0.00
Stochastic Oscillator 5.13 4.00

Price Performance

Historical Comparison
GALT
DSAC

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares

Daedalus Special Acquisition Corp is a blank check company.

Share on Social Networks: